FY2025 Earnings Forecast for Zoetis Issued By William Blair

Zoetis Inc. (NYSE:ZTS) – Equities research analysts at William Blair increased their FY2025 earnings per share estimates for Zoetis in a research note issued to investors on Tuesday, November 4th. William Blair analyst B. Vazquez now forecasts that the company will earn $6.33 per share for the year, up from their prior estimate of $6.29. The consensus estimate for Zoetis’ current full-year earnings is $6.07 per share. William Blair also issued estimates for Zoetis’ Q3 2026 earnings at $1.77 EPS.

Several other equities research analysts have also issued reports on ZTS. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and lowered their target price for the stock from $180.00 to $155.00 in a research note on Thursday, July 17th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Stifel Nicolaus set a $140.00 price target on Zoetis in a research report on Tuesday. Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a report on Thursday, July 17th. Finally, UBS Group cut their price objective on Zoetis from $158.00 to $141.00 and set a “neutral” rating for the company in a research report on Wednesday. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Zoetis has a consensus rating of “Moderate Buy” and a consensus target price of $191.00.

Zoetis Price Performance

Shares of NYSE ZTS opened at $119.81 on Friday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The stock has a market capitalization of $53.10 billion, a price-to-earnings ratio of 20.62, a PEG ratio of 2.31 and a beta of 0.90. The firm’s 50 day simple moving average is $144.93 and its 200-day simple moving average is $152.78. Zoetis has a 12 month low of $119.06 and a 12 month high of $181.85.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, beating the consensus estimate of $1.62 by $0.08. The business had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS.

Hedge Funds Weigh In On Zoetis

Several hedge funds and other institutional investors have recently made changes to their positions in ZTS. Lindbrook Capital LLC raised its stake in Zoetis by 1.8% in the 1st quarter. Lindbrook Capital LLC now owns 3,715 shares of the company’s stock valued at $612,000 after purchasing an additional 65 shares during the last quarter. Scott & Selber Inc. grew its holdings in shares of Zoetis by 0.6% during the second quarter. Scott & Selber Inc. now owns 11,652 shares of the company’s stock worth $1,817,000 after buying an additional 67 shares in the last quarter. North Star Asset Management Inc. raised its position in shares of Zoetis by 4.9% in the second quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock valued at $225,000 after buying an additional 67 shares during the last quarter. Secure Asset Management LLC lifted its stake in shares of Zoetis by 2.9% in the second quarter. Secure Asset Management LLC now owns 2,448 shares of the company’s stock worth $382,000 after buying an additional 68 shares in the last quarter. Finally, Quotient Wealth Partners LLC lifted its stake in shares of Zoetis by 2.3% in the first quarter. Quotient Wealth Partners LLC now owns 3,167 shares of the company’s stock worth $521,000 after buying an additional 72 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Zoetis Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.7%. The ex-dividend date is Friday, October 31st. Zoetis’s payout ratio is 33.67%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.